Ballard Power's Blistering Rally Puts It Above Every Analyst Target as Bus Pipeline Powers Momentum

Ballard Power Systems hits 52-week high of €5.34, surpassing every Wall Street target, driven by Q1 revenue growth, positive gross margins, and cost cuts. But backlog dip and major shareholder selling raise caution.

Ballard Power Systems has achieved what few turnaround stories manage: its stock now trades above every Wall Street price target in sight. The fuel-cell maker hit a fresh 52-week high of €5.27 yesterday and has since edged to €5.34, extending a 12-month gain of roughly 320%. That leaves the average analyst estimate of $3.59 to $4.19 per share trailing by a wide margin — and the disconnect is sharpening by the day.

The rally has been driven by concrete financial improvements, not just sector euphoria. In the first quarter of 2026, Ballard reported revenue of $19.4 million, a 26% year-over-year jump. More importantly, gross margin swung positive for the third consecutive quarter, landing at 14%. Operating expenses fell 36%, and the adjusted EBITDA loss narrowed from $27.5 million to $11.4 million. Cash burn from operations shrank by two-thirds to just $7.8 million, leaving the company with $516.8 million in liquidity and a current ratio of nearly 10.

Those numbers have started to convince institutional observers. Lake Street Capital Markets upgraded the stock to Buy, pointing to the new bus contracts and the potential for Ballard to enter the data-center backup power market. The company has secured multi-year supply agreements with Solaris Bus & Coach through 2029 and an exclusive deal with Wrightbus for its double-decker StreetDeck Hydroliner Gen 3.0, with series production scheduled for 2027.

Yet not every signal is bullish. Ballard’s order backlog stood at $112.9 million at quarter-end, down 5% from the prior period, and the 12-month backlog dipped slightly to $52.8 million. Management has refrained from issuing specific revenue or profit guidance for the full year, citing the early stage of the hydrogen industry. The company still expects a stronger second half, but uncertainty persists.

Adding to the complexity, Ballard’s largest shareholder, China’s Weichai, sold roughly 6.9 million shares in recent weeks, reducing its stake to about 10.3%. Two Weichai-nominated directors resigned from the board in mid-May, a move that increases the company’s operational independence but also removes a major strategic ally. On the technical side, the stock’s relative strength index sits at 24.4, deep in overbought territory, while annualized volatility runs at 127%.

The crucial question now is whether the operational turnaround can sustain the momentum. Ballard has delivered on cost discipline and margin improvement, but translating the contract wins into sustained revenue growth — and eventually free cash flow — will determine whether the stock can hold its ground above analyst targets. The next quarterly report will either validate the rally or expose a gap between market enthusiasm and business reality.